Literature DB >> 11991646

Lead(II) as a probe for investigating RNA structure in vivo.

Magnus Lindell1, Pascale Romby, E Gerhart H Wagner.   

Abstract

In this communication, we describe a simple and reliable method for RNA structure determination in vivo, using the divalent ion, lead(II), as a structural probe. Lead(II) is known to cleave RNA within single-stranded regions, loops, and bulges, whereas cleavages in double-stranded regions are weaker or absent. Because the ion easily entered bacterial cells, Escherichia coli cultures were treated by addition of 50-100 mM lead(II) acetate for 3-7 min, resulting in partial cleavage of RNA in vivo. Cleavage positions were mapped by reverse transcription analysis of total extracted RNA. Three RNAs were analyzed: tmRNA, CopT (the target of the antisense RNA CopA), and the leader region of the ompF mRNA. All three RNAs had previously been analyzed in vitro, and secondary structure models were available. The results presented here show that lead(II) cleavages in vivo yield detailed structural information for these RNAs, which was in good agreement with the models proposed based on in vitro work. These data illustrate the potential of lead(II) as a sequence-independent RNA structure probe for use in living cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991646      PMCID: PMC1370274          DOI: 10.1017/s1355838201020416

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  34 in total

1.  An unusual structure formed by antisense-target RNA binding involves an extended kissing complex with a four-way junction and a side-by-side helical alignment.

Authors:  F A Kolb; C Malmgren; E Westhof; C Ehresmann; B Ehresmann; E G Wagner; P Romby
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

2.  Progression of a loop-loop complex to a four-way junction is crucial for the activity of a regulatory antisense RNA.

Authors:  F A Kolb; H M Engdahl; J G Slagter-Jäger; B Ehresmann; C Ehresmann; E Westhof; E G Wagner; P Romby
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

3.  Leadzyme.

Authors:  L David; D Lambert; P Gendron; F Major
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

4.  Use of lead(II) to probe the structure of large RNA's. Conformation of the 3' terminal domain of E. coli 16S rRNA and its involvement in building the tRNA binding sites.

Authors:  P Gornicki; F Baudin; P Romby; M Wiewiorowski; W Kryzosiak; J P Ebel; C Ehresmann; B Ehresmann
Journal:  J Biomol Struct Dyn       Date:  1989-04

5.  In vivo and in vitro structural analysis of the rplJ mRNA leader of Escherichia coli. Protection by bound L10-L7/L12.

Authors:  S C Climie; J D Friesen
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

6.  Secondary structure analysis of the RepA mRNA leader transcript involved in control of replication of plasmid R1.

Authors:  M Ohman; E G Wagner
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

Review 7.  Probing the structure of RNAs in solution.

Authors:  C Ehresmann; F Baudin; M Mougel; P Romby; J P Ebel; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

8.  The function of micF RNA. micF RNA is a major factor in the thermal regulation of OmpF protein in Escherichia coli.

Authors:  J Andersen; S A Forst; K Zhao; M Inouye; N Delihas
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

9.  Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA.

Authors:  R S Brown; J C Dewan; A Klug
Journal:  Biochemistry       Date:  1985-08-27       Impact factor: 3.162

10.  A pSC101-derived plasmid which shows no sequence homology to other commonly used cloning vectors.

Authors:  G Churchward; D Belin; Y Nagamine
Journal:  Gene       Date:  1984-11       Impact factor: 3.688

View more
  34 in total

Review 1.  Folding and finding RNA secondary structure.

Authors:  David H Mathews; Walter N Moss; Douglas H Turner
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-04       Impact factor: 10.005

2.  Two antisense RNAs target the transcriptional regulator CsgD to inhibit curli synthesis.

Authors:  Erik Holmqvist; Johan Reimegård; Maaike Sterk; Nina Grantcharova; Ute Römling; Eduard Gerhart Heinrich Wagner
Journal:  EMBO J       Date:  2010-04-20       Impact factor: 11.598

Review 3.  RNA folding in living cells.

Authors:  Georgeta Zemora; Christina Waldsich
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

4.  Lead(II) cleavage analysis of RNase P RNA in vivo.

Authors:  Magnus Lindell; Mathias Brännvall; E Gerhart H Wagner; Leif A Kirsebom
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

5.  Generating new specific RNA interaction interfaces using C-loops.

Authors:  Kirill A Afonin; Neocles B Leontis
Journal:  J Am Chem Soc       Date:  2006-12-20       Impact factor: 15.419

Review 6.  RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.

Authors:  Peixuan Guo
Journal:  J Nanosci Nanotechnol       Date:  2005-12

7.  Structure probing of tmRNA in distinct stages of trans-translation.

Authors:  Natalia Ivanova; Magnus Lindell; Michael Pavlov; Lovisa Holmberg Schiavone; E Gerhart H Wagner; Måns Ehrenberg
Journal:  RNA       Date:  2007-03-30       Impact factor: 4.942

8.  Comparative and integrative analysis of RNA structural profiling data: current practices and emerging questions.

Authors:  Krishna Choudhary; Fei Deng; Sharon Aviran
Journal:  Quant Biol       Date:  2017-03-30

Review 9.  Identifying and characterizing Hfq-RNA interactions.

Authors:  M A Faner; A L Feig
Journal:  Methods       Date:  2013-05-23       Impact factor: 3.608

10.  Influence of nucleotide identity on ribose 2'-hydroxyl reactivity in RNA.

Authors:  Kevin A Wilkinson; Suzy M Vasa; Katherine E Deigan; Stefanie A Mortimer; Morgan C Giddings; Kevin M Weeks
Journal:  RNA       Date:  2009-05-20       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.